Trial intelligence / Profile preview

Comparison of hypotensive effect induced by remimazolam and propofol during total intravenous anesthesia in the elderly

KCT0006719Phase 4Completed

Sponsor
Hana Pharm
Start
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of remimazolam, propofol, sponsored by Hana Pharm. Started Nov 2021; status: completed.

02

Drugs

remimazolampropofol

Beyond the preview

Go deeper on KCT0006719.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0006719.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call